Your browser is no longer supported. Please, upgrade your browser.
SIGA SIGA Technologies, Inc. daily Stock Chart
SIGA Technologies, Inc.
Index- P/E7.37 EPS (ttm)0.62 Insider Own2.50% Shs Outstand85.18M Perf Week-5.77%
Market Cap389.27M Forward P/E- EPS next Y- Insider Trans1.79% Shs Float53.68M Perf Month-12.28%
Income49.70M PEG7.37 EPS next Q- Inst Own34.40% Short Float5.12% Perf Quarter-10.39%
Sales24.00M P/S16.22 EPS this Y- Inst Trans1.79% Short Ratio13.01 Perf Half Y-9.50%
Book/sh1.27 P/B3.60 EPS next Y- ROA24.30% Target Price11.00 Perf Year-33.09%
Cash/sh0.92 P/C4.98 EPS next 5Y1.00% ROE47.80% 52W Range4.21 - 7.03 Perf YTD-4.19%
Dividend- P/FCF- EPS past 5Y77.90% ROI249.60% 52W High-34.42% Beta0.01
Dividend %- Quick Ratio8.00 Sales past 5Y144.00% Gross Margin92.70% 52W Low9.50% ATR0.22
Employees41 Current Ratio8.40 Sales Q/Q-98.30% Oper. Margin-18.10% RSI (14)41.53 Volatility4.14% 4.44%
OptionableYes Debt/Eq0.77 EPS Q/Q-100.30% Profit Margin- Rel Volume0.34 Prev Close4.57
ShortableYes LT Debt/Eq0.77 EarningsMar 05 AMC Payout0.00% Avg Volume211.40K Price4.61
Recom- SMA20-5.80% SMA50-5.96% SMA200-12.29% Volume54,275 Change0.88%
Feb-20-20 04:59PM  SIGA to Host Business Update Call on March 5, 2020 after Release of Year End Financial Results GlobeNewswire
Dec-19-19 06:08PM  Hedge Funds Are Betting On SIGA Technologies Inc. (SIGA) Insider Monkey
Dec-05-19 12:10PM  SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX® GlobeNewswire
Nov-18-19 07:30AM  SIGA Announces Canadian Release of the Advanced Contract Award Notice to Support Regulatory Filing for Oral TPOXX® GlobeNewswire
Nov-14-19 09:01AM  Do Institutions Own SIGA Technologies, Inc. (NASDAQ:SIGA) Shares? Simply Wall St.
Oct-31-19 02:20PM  Here is What Hedge Funds Think About SIGA Technologies Inc. (SIGA) Insider Monkey
Oct-21-19 07:30AM  SIGA Technologies CEO to Speak at NCT Asia Conference on October 23, 2019 GlobeNewswire
Oct-03-19 07:30AM  SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020 GlobeNewswire
Sep-26-19 07:30AM  SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019 GlobeNewswire
Sep-25-19 07:30AM  SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019 GlobeNewswire
Aug-28-19 07:30AM  SIGA to Present at the 14th Annual Wells Fargo Securities Healthcare Conference on September 5, 2019 GlobeNewswire
Jul-08-19 07:30AM  SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXX® as Post-Exposure Prophylactic for Smallpox GlobeNewswire
Jun-27-19 11:18AM  Hedge Funds Have Never Been This Bullish On SIGA Technologies Inc. (SIGA) Insider Monkey
Jun-18-19 07:30AM  SIGA Technologies CEO to Speak at NCT Europe on June 27, 2019 GlobeNewswire
Jun-11-19 07:30AM  SIGA Technologies to Host Business Update Webcast on June 18, 2019 GlobeNewswire -8.10%
Jun-03-19 07:30AM  SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets GlobeNewswire
May-26-19 08:22AM  Oaktree Capital Managements Latest Moves Insider Monkey
May-20-19 04:30PM  SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXX® Manufacturing Totaling $11 Million GlobeNewswire
May-08-19 02:26PM  Hedge Funds Have Never Been This Bullish On SIGA Technologies Inc. (SIGA) Insider Monkey
Mar-26-19 05:33PM  6 Low Price-Earnings Stocks
Feb-21-19 07:30AM  SIGA to Present at the 8th Annual SVB Leerink Global Healthcare Conference on March 1, 2019 GlobeNewswire
Nov-15-18 08:15AM  Report: Developing Opportunities within NeuroMetrix, Sunesis Pharmaceuticals, Siga Technologies, NexPoint Residential Trust, Frequency Electronics, and Horizon Technology Finance Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-06-18 03:35PM  How Immersion Corporation (IMMR) Stacks Up Against Its Market Cap Peers Insider Monkey
Nov-01-18 07:30AM  SIGA Announces Priority Review Voucher Transaction Totaling $80 Million GlobeNewswire
Oct-09-18 12:00PM  Orchestra BioMed Adds Three Industry Leaders to Strategic Advisory Board GlobeNewswire
Oct-04-18 07:30AM  SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox GlobeNewswire
Sep-27-18 07:30AM  SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018 GlobeNewswire
Sep-17-18 07:30AM  SIGA Technologies to Host Business Update Webcast on September 27, 2018 GlobeNewswire
Sep-13-18 04:01PM  SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018 GlobeNewswire
Sep-10-18 05:50PM  SIGA Technologies Awarded BARDA Contract for TPOXX® GlobeNewswire
Jul-16-18 10:42AM  Siga Continues Rally After FDA Approves Smallpox Drug Benzinga
Jul-13-18 03:47PM  U.S. Food and Drug Administration Approves SIGA Technologies TPOXX® (tecovirimat) for the Treatment of Smallpox GlobeNewswire +17.79%
03:33PM  SIGA Technologies shares rise 10% on approval of first-ever smallpox therapy MarketWatch
Jul-05-18 07:30AM  Pivotal Trial Data for SIGA Technologies Oral TPOXX® Published in the New England Journal of Medicine GlobeNewswire
May-31-18 07:30AM  SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018 GlobeNewswire
May-03-18 08:31AM  Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss Benzinga
May-02-18 07:41AM  Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings Benzinga +10.36%
May-01-18 04:03PM  SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX® GlobeNewswire
07:05AM  SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXX® GlobeNewswire
Feb-27-18 08:30AM  Emerging Developments: New Research on Siga Technologies and Tropicana Entertainment - A Look Ahead into 2018 ACCESSWIRE
Aug-25-17 10:58AM  SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kane JulieDirectorDec 09Buy4.392,50010,9752,500Dec 10 04:39 PM
SAVAS PAUL GDirectorDec 09Buy4.3720,00087,400292,847Dec 10 04:40 PM
Luckshire Daniel JExecutive VP & CFODec 09Buy4.395,00021,950224,943Dec 10 04:37 PM
Gomez Phillip Louis IIIChief Executive OfficerDec 09Buy4.4210,00044,200475,782Dec 10 04:37 PM
Gomez Phillip Louis IIIChief Executive OfficerNov 22Option Exercise0.00294,1170609,810Nov 26 07:12 PM
ROSE ERIC A MDDirectorNov 22Option Exercise0.00100,00001,093,094Nov 26 07:08 PM